A detailed history of Baillie Gifford & CO transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 10,656,279 shares of SANA stock, worth $57.8 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
10,656,279
Previous 10,150,017 4.99%
Holding current value
$57.8 Million
Previous $41.4 Million 157.32%
% of portfolio
0.08%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$4.2 - $11.27 $2.13 Million - $5.71 Million
506,262 Added 4.99%
10,656,279 $107 Million
Q4 2023

Jan 26, 2024

SELL
$2.8 - $4.55 $152,202 - $247,328
-54,358 Reduced 0.53%
10,150,017 $41.4 Million
Q3 2023

Nov 13, 2023

SELL
$3.77 - $6.23 $2.38 Million - $3.94 Million
-631,786 Reduced 5.83%
10,204,375 $39.5 Million
Q2 2023

Jul 28, 2023

SELL
$3.22 - $7.53 $131,272 - $306,983
-40,768 Reduced 0.37%
10,836,161 $64.6 Million
Q1 2023

May 03, 2023

BUY
$3.11 - $4.92 $348,948 - $552,033
112,202 Added 1.04%
10,876,929 $35.6 Million
Q4 2022

Jan 24, 2023

SELL
$3.19 - $6.46 $644,408 - $1.3 Million
-202,009 Reduced 1.84%
10,764,727 $42.5 Million
Q3 2022

Oct 27, 2022

SELL
$5.58 - $9.04 $249,571 - $404,323
-44,726 Reduced 0.41%
10,966,736 $65.8 Million
Q2 2022

Aug 08, 2022

SELL
$4.12 - $9.35 $306,523 - $695,630
-74,399 Reduced 0.67%
11,011,462 $70.8 Million
Q1 2022

May 05, 2022

SELL
$5.24 - $15.58 $923,125 - $2.74 Million
-176,169 Reduced 1.56%
11,085,861 $91.6 Million
Q4 2021

Jan 20, 2022

BUY
$15.18 - $23.15 $1.1 Million - $1.67 Million
72,198 Added 0.65%
11,262,030 $174 Million
Q3 2021

Oct 19, 2021

SELL
$16.29 - $25.88 $847,389 - $1.35 Million
-52,019 Reduced 0.46%
11,189,832 $252 Million
Q2 2021

Aug 02, 2021

BUY
$16.65 - $32.14 $20.9 Million - $40.3 Million
1,254,306 Added 12.56%
11,241,851 $221 Million
Q1 2021

May 06, 2021

BUY
$23.04 - $43.5 $230 Million - $434 Million
9,987,545 New
9,987,545 $334 Million

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $1.03B
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.